Cardinal Health Board Of Directors Raises Quarterly Dividend

         Cardinal Health Board Of Directors Raises Quarterly Dividend

PR Newswire

DUBLIN, Ohio, Oct. 30, 2012

DUBLIN, Ohio, Oct. 30, 2012 /PRNewswire/ --Cardinal Health today announced
that its board of directors has approved a 16 percent increase in the
company's quarterly dividend to $0.275 per share, or $1.10 per share on an
annualized basis.

The quarterly dividend is payable on Jan. 15, 2013, to shareholders of record
at the close of business on Jan. 2, 2013.

The dividend increase is in addition to a 10.5 percent increase realized in
July 2012. This action represents the company's continued commitment to total
shareholder return through strategic investments for future growth, dividend
payouts and share repurchase.

About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $108
billion health care services company that improves the cost-effectiveness of
health care. As the business behind health care, Cardinal Health helps
pharmacies, hospitals, ambulatory surgery centers and physician offices focus
on patient care while reducing costs, enhancing efficiency and improving
quality. Cardinal Health is an essential link in the health care supply chain,
providing pharmaceuticals and medical products to more than 60,000 locations
each day. The company is also a leading manufacturer of medical and surgical
products, including gloves, surgical apparel and fluid management products. In
addition, the company supports the growing diagnostic industry by supplying
medical products to clinical laboratories and operating the nation's largest
network of radiopharmacies that dispense products to aid in the early
diagnosis and treatment of disease. Ranked #21 on the Fortune 500, Cardinal
Health employs more than 30,000 people worldwide. More information about the
company may be found at and @CardinalHealth on Twitter.

This news release contains forward-looking statements addressing expectations,
prospects, estimates and other matters that are dependent upon future events
or developments. These statements may be identified by words such as "expect,"
"anticipate," "intend," "plan," "believe," "will," "should," "could," "would,"
"project," "continue," "likely," and similar expressions, and include
statements reflecting future results or guidance, statements of outlook and
expense accruals. These matters are subject to risks and uncertainties that
could cause actual results to differ materially from those projected,
anticipated or implied. These risks and uncertainties include competitive
pressures in Cardinal Health's various lines of business; the loss of one or
more key customer or supplier relationships or changes to the terms of those
relationships, including our relationships with CVS Caremark Corporation and
Walgreen Co.; the timing of generic and branded pharmaceutical introductions
and the frequency or rate of pharmaceutical price appreciation or deflation;
uncertainties due to government health care reform including federal health
care reform legislation; changes in the distribution patterns or reimbursement
rates for health care products and services; the effects of any investigation
or action by any regulatory authority; changes in the cost of commodities such
as oil-based resins, cotton, latex and diesel fuel; uncertainties concerning
Cardinal Health's ability to achieve the expected benefits of its Medical
segment's business transformation project; and with respect to future
dividends, the decision by Cardinal Health's board of directors to declare
such dividends, which decision will depend on Cardinal Health's surplus,
earnings, cash flows, financial condition and prospects at the time any such
action is considered. Cardinal Health is subject to additional risks and
uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K
reports and exhibits to those reports. This news release reflects management's
views as of October 30, 2012. Except to the extent required by applicable law,
Cardinal Health undertakes no obligation to update or revise any
forward-looking statement.

SOURCE Cardinal Health

Contact: Media: Debbie Mitchell, +1-614-757-6225,; Investors: Sally Curley, +1-614-757-7115,
Press spacebar to pause and continue. Press esc to stop.